CD4+ T cell expansion and activation, driven by DC-mediated antigen presentation, is key for initiating and worsening inflammation and fibrosis in NAFLD in some cases and stages of the disease, but evidence also exists for a role for CD4+ T cells in promoting resolution of inflammation and fibrosis (69, 70). The gene discussed is CD4; the disease is metabolic dysfunction-associated steatotic liver disease.